ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

EPRX Eupraxia Pharmaceuticals Inc

3,67
0,00 (0,00%)
04 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Eupraxia Pharmaceuticals Inc EPRX Toronto Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 3,67 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,67
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
23/5/202423:00PRNUSEupraxia Pharmaceuticals Announces Expansion of RESOLVE..
22/5/202413:00PRNUSEupraxia Pharmaceuticals to Host Virtual KOL Event on..
21/5/202423:00PRNUSEupraxia Pharmaceuticals Announces New Positive Data from..
14/5/202413:00PRNUSEupraxia Pharmaceuticals to Present Initial Results from..
08/5/202423:03PRNUSEupraxia Pharmaceuticals Reports First Quarter 2024..
02/5/202413:00PRNUSEupraxia Pharmaceuticals Announces Gastrointestinal Clinical..
11/4/202413:00PRNUSEupraxia Pharmaceuticals Announces Upcoming Presentations at..
08/4/202413:00PRNUSEupraxia Pharmaceuticals To Present at Bloom Burton & Co...
05/4/202413:00PRNUSEupraxia Pharmaceuticals Begins Trading on Nasdaq Today
03/4/202423:00PRNCAEupraxia Pharmaceuticals to Begin Trading on Nasdaq on April..
01/4/202423:01PRNCAEupraxia Pharmaceuticals Reports Fourth Quarter and 2023..
15/3/202413:26GLOBEEupraxia Pharmaceuticals Announces Closing of Overnight..
12/3/202414:41PRNCAL'Organisme canadien de réglementation des investissements..
12/3/202414:39PRNCACanadian Investment Regulatory Organization Trade Resumption..
12/3/202414:31GLOBEEupraxia Pharmaceuticals Announces Pricing of Overnight..
11/3/202421:08GLOBEEupraxia Pharmaceuticals Announces Overnight Marketed..
11/3/202421:06PRNCASuspension de la négociation par l'Organisme canadien de..
11/3/202421:04PRNCACanadian Investment Regulatory Organization Trading Halt -..
05/2/202423:00PRNCAEupraxia Pharmaceuticals Announces Updated Positive Clinical..
01/2/202413:00PRNCAEupraxia Pharmaceuticals Initiates Phase 3 Development..
30/1/202413:00PRNCAEupraxia Pharmaceuticals Announces Positive Data from MRI..
09/1/202400:44PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
12/12/202313:00PRNCAEupraxia Pharmaceuticals Announces Positive Clinical Data in..
11/12/202313:00PRNCAEupraxia Pharmaceuticals Announces Clinical and Corporate..
14/11/202323:01PRNCAEupraxia Pharmaceuticals Reports Third Quarter 2023..
01/11/202312:00PRNCAEupraxia Pharmaceuticals to Present at the 2023 Annual..
11/10/202313:00PRNCAEupraxia Pharmaceuticals Announces Initiation of Second..
11/9/202321:32PRNCAEupraxia Pharmaceuticals to Present at the H.C. Wainwright..
07/9/202323:00PRNCAEupraxia Pharmaceuticals Announces Change of Auditor
06/9/202323:00PRNCAEupraxia Pharmaceuticals Announces Presentation at PAINWeek..
19/8/202301:20PRNCAEupraxia Pharmaceuticals Announces Closing of Non-Brokered..
11/8/202323:00PRNCAEupraxia Pharmaceuticals Reports Second Quarter 2023..
04/8/202313:00PRNCAEupraxia Pharmaceuticals Announces a Non-Brokered Private..
26/6/202313:00PRNCAEupraxia Pharmaceuticals Reports Positive Topline Data in..
16/6/202300:42PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
13/6/202317:04DJNEupraxia Shares Climb After FDA Fast-Track Designation for..
13/6/202313:43DJNEupraxia Pharmaceuticals Gets FDA Fast-Track Designation for..
13/6/202313:00PRNCAEupraxia Pharmaceuticals Receives U.S. FDA Fast Track..
08/6/202313:00PRNCAEupraxia Pharmaceuticals Doses First Patient in Phase 1b/2a..

Dernières Valeurs Consultées

Delayed Upgrade Clock